ACE inhibitors are a standard heart failure medication, targeting a range of physiologic processes to mediate adverse remodeling and improve cardiac function by reducing pre- and afterload, and dampening neurohumoral activation upstream of the myocardium to improve ejection fraction [16, 17]. This evidence concerns the gene ACE and heart failure.